SNTI News Alert Senesco Technologies Inc (SNTI) 1.6000 09/21/2014

New Post Public Reply Private Reply Replies (0) Message Board

Sep 21, 2014 at 4:38 AM

Senesco Technologies Inc (SNTI) 1.6000 $SNTI

Senesco Announces Corporate Rebranding to Sevion Therapeutics
Business Wire - Tue Sep 09, 7:15AM CDT
Senesco Technologies, Inc. (OTCQB:SNTI) (the "Company" or "Sevion"

, a clinical-stage company which discovers, develops and acquires next-generation biologics for the treatment of cancer and immunological diseases, announced today a corporate rebranding under which the Company will change its name to Sevion Therapeutics, Inc. The Company will continue to trade as SNTI until a new ticker symbol is obtained. The rebranding and new corporate identity are first steps in fulfilling the Company's goal of becoming a preeminent, next-generation biologics company with best- and first-in-class product candidates and technologies.

Senesco concludes patient admission in Phase 1b/2a SNS01-T Study in B-cell cancers
M2 - Mon Sep 01, 5:15AM CDT
Biotech company Senesco Technologies (OTC BB:SNTI) revealed on Friday the completion of enrollment in its ongoing Phase 1b/2a open-label, multiple-dose, dose-escalation clinical trial of SNS01-T in patients with relapsed or refractory multiple myeloma, plasma cell leukemia or B cell lymphoma.

Senesco Closes Enrollment in Its Phase 1b/2a SNS01-T Study
Business Wire - Fri Aug 29, 7:15AM CDT
Senesco Technologies, Inc. ("Senesco" or the "Company"

(OTCQB:SNTI) today announced the closing of enrollment in its ongoing Phase 1b/2a open-label, multiple-dose, dose-escalation clinical trial of SNS01-T, a first-in-class modulator of eukaryotic translation initiation factor 5A (eIF5A), in patients with relapsed or refractory multiple myeloma, plasma cell leukemia or B cell lymphoma.

Senesco names Ronald A. Martell as new CEO
M2 - Thu Jun 26, 4:54AM CDT
Biotech company Senesco Technologies (OTC BB:SNTI) revealed on Wednesday the election of Ronald A. Martell as chief executive officer at the 2014 BIO International Convention in San Diego.

Senesco Presents Company Update at 2014 BIO International Convention
Business Wire - Wed Jun 25, 1:05PM CDT
Senesco Technologies, Inc. ("Senesco" or the "Company"

(OTCQB:SNTI) provided an overview of the company's current research and development status at the 2014 BIO International Convention in San Diego. Acting CEO, Vaughn V. Smider, M.D., Ph.D., presented the update, including the announcement of the completion of the administrative and financial integration of Fabrus with Senesco. The presentation will also be released in an 8-K filing and can be accessed via the company's website.

Senesco Technologies, Inc. - "Reconsidering the Entire Cancer Treatment Approach"
ACCESSWIRE - Tue Apr 01, 10:47AM CDT
BRIDGEWATER, NJ / ACCESSWIRE / April 1, 2014 / Senesco Technologies, Inc. (OTCQB: SNTI) today published a new blog post on The Chairman's Blog, written by the Company's President and CEO, Dr. Leslie J. Browne. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.

Senesco Opens Two New Clinical Trial Sites and Initiates Treatment of the First Patient in South Africa
Business Wire - Wed Mar 12, 7:15AM CDT
Senesco Technologies, Inc. ("Senesco" or the "Company"

(OTCQB:SNTI) reported the opening of two new sites in the Republic of South Africa at Pretoria East Hospital and Groote Schuur Hospital in Cape Town. Treatment of the first patient in South Africa has been initiated in Senesco's Phase 1b/2a clinical study of its product candidate, SNS01-T.

Senesco pays off line of credit held by JMP Securities
M2 - Tue Mar 11, 9:34AM CDT
Senesco Technologies Inc (OTCBB:SNTI), a clinical-stage biotech company specializing in cancer therapeutics, announced on Monday that is has paid in full and cancelled the line of credit held by JMP Securities.

Senesco Pays Off Line of Credit
Business Wire - Mon Mar 10, 7:15AM CDT
Senesco Technologies, Inc. ("Senesco" or the "Company"

(OTCQB: SNTI) announces that is has paid in full and canceled the line of credit held by JMP Securities (the "Line of Credit"

.

Dean Foods Reports Fourth Quarter And Full Year 2013 Results
PR Newswire - Tue Feb 11, 7:00AM CST
Dean Foods Company (NYSE: DF) today announced that the Company earned $8.58 per diluted share for the full year 2013, as compared to $1.70 per diluted share for the full year 2012. Full year 2013 reported results include the gain on disposition of WhiteWave common stock of $416 million, the gain on sale of Morningstar of $492 million (net of tax) and other one-time or non-recurring items, as more fully described in the attached tables. On an adjusted basis, the Company earned $0.86 per diluted share for the full year 2013, compared to $0.77 for the full year 2012.

Senesco Technologies Reports Fiscal Year 2013 Financial Results
Business Wire - Thu Sep 12, 7:30AM CDT
Senesco Technologies, Inc. ("Senesco" or the "Company"

(OTCQB:SNTI) today announced financial results for the 12 months ended June 30, 2013 ("Fiscal 2013"

.

OTC Daily Alert Stock Watch - Senesco Technologies, Inc. (OTCQB:SNTI)
WorldStockWire - Wed Aug 07, 2:00AM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com

Senesco Announces Results of Cohort 2 of its SNS01-T Phase 1b/2a Trial
Business Wire - Wed Jun 19, 7:30AM CDT
Senesco Technologies, Inc. ("Senesco" or the "Company"

(OTC QB: SNTI) reported results of cohort 2 in its Phase 1b/2a clinical study of SNS01-T.

Senesco Technologies Reports Second Quarter Fiscal 2013 Financial Results
Business Wire - Thu May 16, 7:30AM CDT
Senesco Technologies, Inc. ("Senesco" or the "Company"

(OTCQB: SNTI) today reported financial results for the third quarter of fiscal year 2013 which ended on March 31, 2013.

Senesco Technologies Inc expects USD1.255m in equity financing
M2 - Fri May 10, 12:59PM CDT
Cancer therapy company Senesco Technologies Inc (OTC BB:SNTI) revealed on Thursday the execution of a USD1.255m securities purchase agreement with certain institutional investors.

Senesco Announces Start of Cohort 3 in Phase 1b/2a Study in Multiple Myeloma and Non-Hodgkins B-Cell Lymphoma
Business Wire - Mon May 06, 7:30AM CDT
Senesco Technologies, Inc. ("Senesco" or the "Company"

(OTC QB: SNTI) reported today that the Data Review Committee (DRC) for its SNS01-T trial in multiple myeloma and non-Hodgkins B-cell lymphoma approved initiating cohort 3 and escalating the SNS01-T dose level four-fold to 0.2 mg/Kg. The DRC's review of the results of cohort 2 concluded that SNS01-T was safe and well tolerated at a dose of 0.05 mg/Kg. No drug-related serious adverse events or dose limiting toxicities were observed in either of the first two cohorts.

Senesco Announces Completion of Cohort 2 of its Phase 1b/2a Trial
Business Wire - Mon Apr 22, 7:30AM CDT
Senesco Technologies, Inc. ("Senesco" or the "Company"

(OTC QB: SNTI) reported today that it has completed cohort 2 in its Phase 1b/2a clinical study of SNS01-T.

Senesco Provides Management Update
Business Wire - Mon Apr 08, 8:15AM CDT
Senesco Technologies, Inc. ("Senesco" or the "Company"

(OTC:SNTI) today announced that Leslie J. Browne, Ph.D., the Company's President and Chief Executive Officer, is being treated for a medical condition that may limit his time to travel and attend public events. However, Dr. Browne will continue with his day-to-day duties and responsibilities as President and CEO of the Company. The Senesco Board has agreed to assist Dr. Browne with certain activities, including Harlan Waksal, M.D., Chairman of Senesco, who will take the lead on certain public activities like investor relations. The Board will continue to monitor Dr. Browne's responsibilities as his treatment progresses.

REIT Companies Join to Webcast Live for Special March 7th RetailInvestorConferences.com Event
CNW Group - Tue Mar 05, 12:14PM CST
Live, online webcasts presentations allow investors to ask questions in real-time and "chat" in virtual trade booths

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Voting for Future Urban Icons Begins Globally

New Era for Urban Innovations Takes Center Stage Here's a twist folks didn't see coming: Future cities aren't just the stuff of sci-fi flicks anymore. We've got a global stage now—real, live, and buzzing with excitement from New Clark City in the Philippines. On October 31, 2026, they pulled back the curtain on 7wondersfc.com, flipping the switch on a worldwide voting...

Alignment Healthcare Faces Investigation Over Alleged Fraud

Rough Waters at Alignment Healthcare Not every day we hear about a company sinking its own ship over bookkeeping shenanigans, but here we are. Alignment Healthcare, sitting on Nasdaq under ticker ALHC, is facing the kind of scrutiny that sends shivers down a boardroom's spine. Yeah, Kahn Swick & Foti—those big hitters in securities litigation—have launched an...

Millrose Properties Faces Legal Storm: Investors Alerted

Millrose Properties: A Storm's Brewing Whoa, step back and take a wide-eyed look at Millrose Properties—there’s a storm brewin’ and it’s a doozy! Right now, they’re up against one mighty class action lawsuit, and investors who’ve been hit for over $100k better circle December 8, 2026, on their calendars if they fancy a shot at lead plaintiff glory. We’re...

HanAll F&B Pioneers New Path for Domestic Rice Noodles

New Spin on an Old Favorite: Rice Noodles Forget about the same old wheat noodles clogging up the pantry. HanAll F&B is revamping the noodle game with a homegrown twist, setting sights on a future where Korean rice isn't just for steaming, soup, or sushi. This outfit from Taebaek, Gangwon, has got its hands deep in the rice flour, finessing a patent that aims to make...

SCANOLOGY's AirGO Pad Revolutionizes On-Site Inspections

Mobile 3D Scanning — Finally, Some Real Innovation Gone are the days where engineers had to cart around bulky laptops just to finish a simple inspection. SCANOLOGY has thrown a real game-changer into the mix with their new AirGO Pad. It's essentially a slick tablet that keeps your scanning, inspecting, and reporting all in one place, right beside whatever tangled hunk...

Wulcea Pioneers Safety in Smart Heated Apparel

Tech Behind the Warmth and Safety You ever turn on a heated jacket and wonder if it'll keep you safe as much as warm? That's the scene with Wulcea, a brand diving headfirst into the smart heated clothing market. People are waking up to what’s inside these technological coats, not just how they feel on a frosty walk. It’s the kind of scenario where safety meets...

PRTH Shareholder Concerns Amid Merger Investigation

Behind Closed Doors: PRTH's Merger Drama Unfolds The market's got its share of tricky maneuvers and right now, Priority Technology Holdings, Inc. (NASDAQ:PRTH) is under the magnifying glass. Levi & Korsinsky, LLP has kicked off an investigation into the nitty-gritty of PRTH's acquisition by its largest shareholder—none other than their own Chairman and CEO, Thomas C....

NIDS Aims Global with CES 2027, Boosts Sensor Supply

Pushing Boundaries at CES 2027 Kicking into high gear, NIDS Co., Ltd. is eyeing the CES 2027 stage like it's their personal gold rush. Already a heavyweight in environmental sensors, the company is all set to seize fresh international opportunities and expand their B2B supply footprint worldwide. Already Turning Heads Founded back in 2000, NIDS ain't new to the sensor...

Generational Happiness: Keio Study Shakes Norms

Happiness Across Generations: New Light from Japan Think happiness is just a personal journey? Well, it turns out there's more to the story when you dive into family ties. A study from Keio University in Japan shakes things up by finding that happiness has a unique way of passing down from parent to child, showing a stronger grip across generations than general or mental...

Sen. Collins Lauded for Transformative Kidney Care

Steering Towards Innovation in Kidney Care In the world of political accolades, real achievements sometimes get buried beneath the pomp. But when the largest kidney patient group in the nation—AAKP, decides to honor Senator Susan M. Collins, it's not just another pat on the back. This one's got substance galore. Collins, a heavyweight on the U.S. Senate Committee on...